Weight Loss with Semaglutide, Tirzepatide & Phentermine Tirzepatide (Mounjaro ) is the first and only approved type 2 diabetes medicine of its kindactivating the receptors of two key hormones to help lower blood sugar levels in adults and children 10 years of age and older with type 2 diabetes, along with diet and exercise
If necessary, the dose can be further increased to 1 mg once a week after a minimum of four weeks on the 0.5 mg dose
All of these agents share the same core pharmacology: they mimic the gut hormone GLP1, which signals satiety, slows gastric emptying, and enhances insulin secretion, leading to reduced appetite and significant, sustained weight loss
Medical Engagement Chatbots Chatbots are becoming increasingly common across all websites, not just healthcare websites
35 Similarly, in a recent study of obese individuals without diabetes, Louis et al demonstrated that tirzepatide (10 or 15 mg) resulted in significantly greater weight loss than semaglutide (1.7 or 2.4 mg) over a 72-week period
